You must be logged in to view this content
This resource is only available for ASCRS Members. Please log in using the teal "Login" button in the top right-hand corner to log in.
Crosslinking is one of the FDA approved treatments for keratoconus. Changes on the standard treatment such as Epi-on crosslinking and oxygen supplementation are reported to be safe and effective. In addition, patients have rapid recover and less pain.
Filed UnderCornea crosslinking keratoconus transepithelial crosslinking epithelium-on epithelium-off riboflavin surgical technique
View More Presentations from SYM-302
This presentation is from the session "SYM-302: Crosslinking Essentials: When to, How to, What to Expect, and What to Avoid" from the 2019 ASCRS Annual Meeting held on May 4-7, 2019 in San Diego, California.